Alaya
Alaya.bio is a preclinical-stage biotechnology company developing in vivo CAR-T cell therapies using a proprietary targeting polymeric nanoparticle platform. The company aims to reprogram immune cells directly inside the patient's body, simplifying the manufacturing process and making cancer treatment faster, safer, and more accessible.